Title：Research on Drugs for New Diabetes, Obesity and Related Metabolic Diseases

Field：Biomedicine

Claim：Technology licensing ,equity investment

Brief：Phyteau's new incretin promoting method activates the body's natural metabolic hormone system and releases key hormones at therapeutic levels, including GLP-1, PYY and CCK, to improve blood glucose level processing, reduce peak blood glucose after meals and increase satiety.

Contact：BAI Lufeng

E-mail：hbst2015@126.com